Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INS37217 (denufosol) in mild to moderate CF
NCT00056147Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of denufosol tetrasodium in cystic fibrosis (CF), sponsored by Merck & Co.. Started Apr 2003; status: completed.
02
Drugs
denufosol tetrasodium
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00056147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00056147.